TELA Bio, Inc. (TELA)
NASDAQ: TELA · IEX Real-Time Price · USD
5.17
+0.20 (4.02%)
Apr 17, 2024, 4:00 PM EDT - Market closed
TELA Bio Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for TELA Bio stock have an average target of 13.67, with a low estimate of 12 and a high estimate of 15. The average target predicts an increase of 164.41% from the current stock price of 5.17.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for TELA Bio stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 2 | 2 | 1 |
| Buy | 2 | 1 | 1 | 1 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 4 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JMP Securities | JMP Securities | Buy Reiterates $15 | Buy | Reiterates | $15 | +190.14% | Mar 22, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $15 → $12 | Buy | Maintains | $15 → $12 | +132.11% | Mar 22, 2024 |
| Lake Street | Lake Street | Strong Buy Reiterates $14 | Strong Buy | Reiterates | $14 | +170.79% | Dec 27, 2023 |
| JMP Securities | JMP Securities | Buy Maintains $20 → $15 | Buy | Maintains | $20 → $15 | +190.14% | Nov 10, 2023 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +190.14% | Mar 28, 2023 |
Financial Forecast
Revenue This Year
76.37M
from 58.45M
Increased by 30.66%
Revenue Next Year
95.67M
from 76.37M
Increased by 25.26%
EPS This Year
-1.78
from -2.04
EPS Next Year
-1.27
from -1.78
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 79.3M | 105.6M | 141.0M | 176.1M | 229.2M |
| Avg | 76.4M | 95.7M | 120.4M | 171.1M | 222.7M |
| Low | 72.5M | 85.6M | 97.3M | 164.4M | 213.9M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 35.6% | 38.3% | 47.4% | 46.3% | 34.0% |
| Avg | 30.7% | 25.3% | 25.8% | 42.1% | 30.1% |
| Low | 24.1% | 12.1% | 1.7% | 36.6% | 25.0% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.66 | -1.03 | -0.41 | -0.21 | 0.22 |
| Avg | -1.78 | -1.27 | -0.79 | -0.20 | 0.21 |
| Low | -1.88 | -1.53 | -0.99 | -0.20 | 0.21 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.